Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO25269 | Ganoderma lucidum | Species | Ganodermataceae | Eukaryota | TM-MC* | |||
NPO16609 | Ganoderma sinense | Species | Ganodermataceae | Eukaryota | TM-MC* | |||
NPO26293 | Ginkgo biloba | Species | Ginkgoaceae | Eukaryota | TM-MC* | |||
NPO25114 | Linum usitatissimum | Species | Linaceae | Eukaryota | TM-MC* | |||
NPO30675 | Vibrio harveyi | Species | Vibrionaceae | Bacteria |
PMID[25668560] |
|||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | DOI[10.1038/nbt.2488] | |||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | saliva |
PMID[22308371] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | blood |
PMID[16131572] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | urine |
PMID[16613999] |
||
NPO20338 | Mus musculus | Species | Muridae | Eukaryota |
PMID[19425150] |
|||
NPO730 | Escherichia coli | Species | Enterobacteriaceae | Bacteria |
PMID[21988831] |
|||
NPO2438 | Euryale ferox | Species | Nymphaeaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | ED50 | = | 55 | ug/ml | 9216836 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | ED50 | = | 78 | ug/ml | 9216836 |
NPT1749 | Organism | Human herpesvirus 3 | Human herpesvirus 3 | ED50 | = | 10.1 | ug/ml | 9216836 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | ED50 | = | 16.8 | ug/ml | 9216836 |
NPT1353 | Cell Line | CCRF-HSB-2 | Homo sapiens | IC50 | = | 2.8 | ug/ml | 9216836 |
NPT1755 | Individual Protein | Thymidine kinase, cytosolic | Homo sapiens | ID50 | = | 0.3 | nM | 1331461 |
NPT2813 | Cell Line | Friend leukemia cell line | ID50 | = | 0.29 | nM | 3861870 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | ID50 | = | 0.49 | nM | 3861870 |
NPT1755 | Individual Protein | Thymidine kinase, cytosolic | Homo sapiens | IC50 | = | 364000 | nM | 12213066 |
NPT1755 | Individual Protein | Thymidine kinase, cytosolic | Homo sapiens | IC50 | = | 115000 | nM | 12213066 |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | ED50 | = | 0.158 | nM | 3172142 |
NPT25 | Cell Line | MT4 | Homo sapiens | CD50 | > | 0.5 | nM | 3172142 |
NPT3560 | Individual Protein | Deoxycytidine kinase | Homo sapiens | Ratio | = | 0.0138 | /s/microM | 18570408 |
NPT3560 | Individual Protein | Deoxycytidine kinase | Homo sapiens | Ratio | = | 0.0129 | /s/microM | 18570408 |
NPT2 | Others | Unspecified | Ratio | = | 0.0051 | /s/microM | 18570408 | |
NPT2 | Others | Unspecified | Ratio | = | 0.0413 | /s/microM | 18570408 | |
NPT2 | Others | Unspecified | Potency | = | 11582.1 | nM | PubChem BioAssay data set | |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 501.2 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 25118.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 20596.2 | nM | PubChem BioAssay data set | ||
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 20587.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 6513.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5804.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3981.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6309.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10322.5 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 29092.9 | nM | PubChem BioAssay data set | |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 85.51 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 90.97 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 22387.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 15848.9 | nM | PubChem BioAssay data set | ||
NPT839 | Cell Line | L6 | Rattus norvegicus | IC50 | > | 250000 | nM | 10.1039/C3MD00159H |
NPT941 | Cell Line | HaCaT | Homo sapiens | IC50 | > | 250000 | nM | 10.1039/C3MD00159H |
NPT76 | Cell Line | C6 | Rattus norvegicus | IC50 | > | 250000 | nM | 10.1039/C3MD00159H |
NPT90 | Cell Line | DU-145 | Homo sapiens | IC50 | > | 250000 | nM | 10.1039/C3MD00159H |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | > | 250000 | nM | 10.1039/C3MD00159H |
NPT1291 | Individual Protein | Purine nucleoside phosphorylase | Homo sapiens | Activity | = | 65 | % | 31484 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC262926 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9919 | High Similarity | NPC61198 |
0.9677 | High Similarity | NPC324009 |
0.96 | High Similarity | NPC319221 |
0.9535 | High Similarity | NPC186619 |
0.9389 | High Similarity | NPC211820 |
0.9389 | High Similarity | NPC251233 |
0.9389 | High Similarity | NPC318590 |
0.9318 | High Similarity | NPC89147 |
0.9318 | High Similarity | NPC274384 |
0.9318 | High Similarity | NPC177169 |
0.9318 | High Similarity | NPC317746 |
0.9248 | High Similarity | NPC64705 |
0.9248 | High Similarity | NPC232408 |
0.9147 | High Similarity | NPC320818 |
0.9008 | High Similarity | NPC30326 |
0.8862 | High Similarity | NPC327579 |
0.8741 | High Similarity | NPC74306 |
0.8741 | High Similarity | NPC315642 |
0.8367 | Intermediate Similarity | NPC14590 |
0.8214 | Intermediate Similarity | NPC21448 |
0.8214 | Intermediate Similarity | NPC107374 |
0.8214 | Intermediate Similarity | NPC156461 |
0.8156 | Intermediate Similarity | NPC164665 |
0.8156 | Intermediate Similarity | NPC189068 |
0.8099 | Intermediate Similarity | NPC219313 |
0.8099 | Intermediate Similarity | NPC309832 |
0.8099 | Intermediate Similarity | NPC269827 |
0.8071 | Intermediate Similarity | NPC229974 |
0.8058 | Intermediate Similarity | NPC161659 |
0.8058 | Intermediate Similarity | NPC209525 |
0.7945 | Intermediate Similarity | NPC321052 |
0.7943 | Intermediate Similarity | NPC314152 |
0.7929 | Intermediate Similarity | NPC317821 |
0.7905 | Intermediate Similarity | NPC52238 |
0.7877 | Intermediate Similarity | NPC85689 |
0.7877 | Intermediate Similarity | NPC185991 |
0.7877 | Intermediate Similarity | NPC211025 |
0.7852 | Intermediate Similarity | NPC54320 |
0.7852 | Intermediate Similarity | NPC313754 |
0.7852 | Intermediate Similarity | NPC311197 |
0.7823 | Intermediate Similarity | NPC321814 |
0.7823 | Intermediate Similarity | NPC472816 |
0.7793 | Intermediate Similarity | NPC121222 |
0.777 | Intermediate Similarity | NPC302778 |
0.777 | Intermediate Similarity | NPC212551 |
0.777 | Intermediate Similarity | NPC164952 |
0.777 | Intermediate Similarity | NPC130586 |
0.7733 | Intermediate Similarity | NPC239737 |
0.7718 | Intermediate Similarity | NPC174802 |
0.7687 | Intermediate Similarity | NPC326694 |
0.7687 | Intermediate Similarity | NPC150853 |
0.7667 | Intermediate Similarity | NPC224076 |
0.7635 | Intermediate Similarity | NPC161224 |
0.7616 | Intermediate Similarity | NPC316618 |
0.7616 | Intermediate Similarity | NPC226245 |
0.7584 | Intermediate Similarity | NPC207633 |
0.75 | Intermediate Similarity | NPC261595 |
0.75 | Intermediate Similarity | NPC136349 |
0.7483 | Intermediate Similarity | NPC129756 |
0.7452 | Intermediate Similarity | NPC324033 |
0.7452 | Intermediate Similarity | NPC321458 |
0.7372 | Intermediate Similarity | NPC323091 |
0.7351 | Intermediate Similarity | NPC328479 |
0.7328 | Intermediate Similarity | NPC313547 |
0.7226 | Intermediate Similarity | NPC195140 |
0.7172 | Intermediate Similarity | NPC33996 |
0.7165 | Intermediate Similarity | NPC59314 |
0.7073 | Intermediate Similarity | NPC189261 |
0.7054 | Intermediate Similarity | NPC119133 |
0.7012 | Intermediate Similarity | NPC326529 |
0.7 | Intermediate Similarity | NPC324484 |
0.6992 | Remote Similarity | NPC41958 |
0.6975 | Remote Similarity | NPC290959 |
0.6975 | Remote Similarity | NPC326082 |
0.697 | Remote Similarity | NPC324198 |
0.697 | Remote Similarity | NPC319100 |
0.6957 | Remote Similarity | NPC325906 |
0.6943 | Remote Similarity | NPC93365 |
0.6929 | Remote Similarity | NPC293163 |
0.6807 | Remote Similarity | NPC313897 |
0.6769 | Remote Similarity | NPC10466 |
0.6765 | Remote Similarity | NPC63433 |
0.6641 | Remote Similarity | NPC320256 |
0.6609 | Remote Similarity | NPC313514 |
0.6527 | Remote Similarity | NPC222174 |
0.6437 | Remote Similarity | NPC24589 |
0.642 | Remote Similarity | NPC78941 |
0.642 | Remote Similarity | NPC282458 |
0.6402 | Remote Similarity | NPC321393 |
0.6347 | Remote Similarity | NPC33382 |
0.6312 | Remote Similarity | NPC240084 |
0.631 | Remote Similarity | NPC125659 |
0.631 | Remote Similarity | NPC168702 |
0.6259 | Remote Similarity | NPC180462 |
0.6139 | Remote Similarity | NPC174020 |
0.6117 | Remote Similarity | NPC157821 |
0.6096 | Remote Similarity | NPC276373 |
0.6064 | Remote Similarity | NPC5802 |
0.6054 | Remote Similarity | NPC109322 |
0.6053 | Remote Similarity | NPC57279 |
0.601 | Remote Similarity | NPC250178 |
0.6 | Remote Similarity | NPC470141 |
0.6 | Remote Similarity | NPC60537 |
0.5956 | Remote Similarity | NPC476561 |
0.5933 | Remote Similarity | NPC144223 |
0.5924 | Remote Similarity | NPC210947 |
0.5921 | Remote Similarity | NPC287876 |
0.5909 | Remote Similarity | NPC51000 |
0.5906 | Remote Similarity | NPC248007 |
0.5886 | Remote Similarity | NPC185903 |
0.5882 | Remote Similarity | NPC470138 |
0.5874 | Remote Similarity | NPC327613 |
0.5864 | Remote Similarity | NPC103388 |
0.5855 | Remote Similarity | NPC14330 |
0.5833 | Remote Similarity | NPC470140 |
0.5823 | Remote Similarity | NPC470139 |
0.5817 | Remote Similarity | NPC246193 |
0.5813 | Remote Similarity | NPC8590 |
0.5802 | Remote Similarity | NPC327477 |
0.58 | Remote Similarity | NPC180493 |
0.5786 | Remote Similarity | NPC286696 |
0.5779 | Remote Similarity | NPC235501 |
0.5775 | Remote Similarity | NPC47936 |
0.5769 | Remote Similarity | NPC126634 |
0.5755 | Remote Similarity | NPC476099 |
0.5753 | Remote Similarity | NPC278549 |
0.5728 | Remote Similarity | NPC107160 |
0.5725 | Remote Similarity | NPC273327 |
0.5721 | Remote Similarity | NPC21461 |
0.5714 | Remote Similarity | NPC104011 |
0.5705 | Remote Similarity | NPC139776 |
0.5705 | Remote Similarity | NPC470142 |
0.5696 | Remote Similarity | NPC237812 |
0.5696 | Remote Similarity | NPC18223 |
0.5677 | Remote Similarity | NPC25465 |
0.5643 | Remote Similarity | NPC476562 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC262926 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9919 | High Similarity | NPD252 | Clinical (unspecified phase) |
0.968 | High Similarity | NPD194 | Clinical (unspecified phase) |
0.9516 | High Similarity | NPD9632 | Phase 3 |
0.9457 | High Similarity | NPD549 | Approved |
0.8913 | High Similarity | NPD3086 | Phase 3 |
0.8862 | High Similarity | NPD9607 | Approved |
0.8841 | High Similarity | NPD3085 | Phase 1 |
0.878 | High Similarity | NPD9606 | Approved |
0.8741 | High Similarity | NPD582 | Approved |
0.8561 | High Similarity | NPD209 | Clinical (unspecified phase) |
0.8542 | High Similarity | NPD4074 | Clinical (unspecified phase) |
0.8537 | High Similarity | NPD9374 | Approved |
0.8413 | Intermediate Similarity | NPD307 | Approved |
0.8374 | Intermediate Similarity | NPD9373 | Approved |
0.8346 | Intermediate Similarity | NPD545 | Clinical (unspecified phase) |
0.8214 | Intermediate Similarity | NPD249 | Approved |
0.8214 | Intermediate Similarity | NPD250 | Approved |
0.8209 | Intermediate Similarity | NPD547 | Clinical (unspecified phase) |
0.8194 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.8099 | Intermediate Similarity | NPD195 | Approved |
0.8099 | Intermediate Similarity | NPD186 | Discovery |
0.8 | Intermediate Similarity | NPD1431 | Approved |
0.8 | Intermediate Similarity | NPD1430 | Approved |
0.7943 | Intermediate Similarity | NPD185 | Approved |
0.7923 | Intermediate Similarity | NPD9409 | Discontinued |
0.7917 | Intermediate Similarity | NPD775 | Approved |
0.7891 | Intermediate Similarity | NPD1369 | Phase 2 |
0.7891 | Intermediate Similarity | NPD1750 | Clinical (unspecified phase) |
0.7877 | Intermediate Similarity | NPD283 | Approved |
0.7857 | Intermediate Similarity | NPD9375 | Discontinued |
0.7852 | Intermediate Similarity | NPD218 | Approved |
0.7852 | Intermediate Similarity | NPD2624 | Phase 2 |
0.7852 | Intermediate Similarity | NPD216 | Approved |
0.7852 | Intermediate Similarity | NPD217 | Approved |
0.7852 | Intermediate Similarity | NPD220 | Clinical (unspecified phase) |
0.7852 | Intermediate Similarity | NPD219 | Phase 3 |
0.7832 | Intermediate Similarity | NPD166 | Approved |
0.7801 | Intermediate Similarity | NPD193 | Suspended |
0.777 | Intermediate Similarity | NPD338 | Approved |
0.777 | Intermediate Similarity | NPD242 | Approved |
0.777 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.777 | Intermediate Similarity | NPD214 | Approved |
0.777 | Intermediate Similarity | NPD3107 | Discontinued |
0.7733 | Intermediate Similarity | NPD2646 | Discontinued |
0.7733 | Intermediate Similarity | NPD1732 | Phase 3 |
0.7718 | Intermediate Similarity | NPD339 | Approved |
0.7667 | Intermediate Similarity | NPD169 | Phase 2 |
0.766 | Intermediate Similarity | NPD1808 | Phase 1 |
0.7643 | Intermediate Similarity | NPD1120 | Approved |
0.7643 | Intermediate Similarity | NPD1121 | Approved |
0.7635 | Intermediate Similarity | NPD353 | Discontinued |
0.7574 | Intermediate Similarity | NPD515 | Phase 1 |
0.75 | Intermediate Similarity | NPD247 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD548 | Clinical (unspecified phase) |
0.7405 | Intermediate Similarity | NPD9584 | Phase 2 |
0.7368 | Intermediate Similarity | NPD9360 | Approved |
0.7351 | Intermediate Similarity | NPD9605 | Phase 3 |
0.7256 | Intermediate Similarity | NPD4716 | Approved |
0.7239 | Intermediate Similarity | NPD237 | Clinical (unspecified phase) |
0.7233 | Intermediate Similarity | NPD2647 | Phase 3 |
0.7212 | Intermediate Similarity | NPD4744 | Clinical (unspecified phase) |
0.7171 | Intermediate Similarity | NPD7842 | Phase 2 |
0.7165 | Intermediate Similarity | NPD8837 | Clinical (unspecified phase) |
0.7117 | Intermediate Similarity | NPD5666 | Phase 2 |
0.7109 | Intermediate Similarity | NPD9626 | Clinical (unspecified phase) |
0.7101 | Intermediate Similarity | NPD798 | Discontinued |
0.7063 | Intermediate Similarity | NPD7988 | Suspended |
0.7054 | Intermediate Similarity | NPD9291 | Approved |
0.7042 | Intermediate Similarity | NPD248 | Discontinued |
0.7024 | Intermediate Similarity | NPD1692 | Approved |
0.7 | Intermediate Similarity | NPD1816 | Clinical (unspecified phase) |
0.697 | Remote Similarity | NPD4171 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.6957 | Remote Similarity | NPD1776 | Approved |
0.6957 | Remote Similarity | NPD1777 | Approved |
0.6943 | Remote Similarity | NPD546 | Clinical (unspecified phase) |
0.6928 | Remote Similarity | NPD1412 | Clinical (unspecified phase) |
0.6901 | Remote Similarity | NPD870 | Clinical (unspecified phase) |
0.6813 | Remote Similarity | NPD516 | Clinical (unspecified phase) |
0.677 | Remote Similarity | NPD3083 | Approved |
0.6744 | Remote Similarity | NPD5684 | Clinical (unspecified phase) |
0.6744 | Remote Similarity | NPD5682 | Phase 3 |
0.6744 | Remote Similarity | NPD6417 | Clinical (unspecified phase) |
0.6744 | Remote Similarity | NPD5683 | Clinical (unspecified phase) |
0.6692 | Remote Similarity | NPD9417 | Phase 3 |
0.6692 | Remote Similarity | NPD9416 | Phase 3 |
0.6667 | Remote Similarity | NPD2630 | Approved |
0.6667 | Remote Similarity | NPD2632 | Approved |
0.6667 | Remote Similarity | NPD2631 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD1368 | Approved |
0.6629 | Remote Similarity | NPD4054 | Clinical (unspecified phase) |
0.6609 | Remote Similarity | NPD7138 | Phase 2 |
0.6531 | Remote Similarity | NPD282 | Approved |
0.651 | Remote Similarity | NPD1119 | Phase 2 |
0.6456 | Remote Similarity | NPD3708 | Phase 2 |
0.6438 | Remote Similarity | NPD1355 | Clinical (unspecified phase) |
0.6438 | Remote Similarity | NPD1356 | Approved |
0.6438 | Remote Similarity | NPD1354 | Approved |
0.6395 | Remote Similarity | NPD9633 | Phase 3 |
0.6369 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.6364 | Remote Similarity | NPD2253 | Discontinued |
0.6346 | Remote Similarity | NPD7158 | Phase 1 |
0.6301 | Remote Similarity | NPD9408 | Phase 3 |
0.6286 | Remote Similarity | NPD9406 | Approved |
0.6276 | Remote Similarity | NPD6381 | Phase 2 |
0.6273 | Remote Similarity | NPD231 | Clinical (unspecified phase) |
0.6223 | Remote Similarity | NPD2876 | Phase 3 |
0.6223 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.6216 | Remote Similarity | NPD1128 | Approved |
0.6216 | Remote Similarity | NPD1127 | Approved |
0.6194 | Remote Similarity | NPD1118 | Discontinued |
0.619 | Remote Similarity | NPD281 | Approved |
0.617 | Remote Similarity | NPD2965 | Clinical (unspecified phase) |
0.6168 | Remote Similarity | NPD5768 | Phase 2 |
0.6162 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.6162 | Remote Similarity | NPD6036 | Suspended |
0.6158 | Remote Similarity | NPD2824 | Phase 2 |
0.6121 | Remote Similarity | NPD2604 | Approved |
0.6115 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.6114 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.6081 | Remote Similarity | NPD4812 | Phase 1 |
0.6039 | Remote Similarity | NPD535 | Approved |
0.6024 | Remote Similarity | NPD3697 | Discontinued |
0.6 | Remote Similarity | NPD2180 | Approved |
0.6 | Remote Similarity | NPD1730 | Discontinued |
0.5957 | Remote Similarity | NPD4599 | Clinical (unspecified phase) |
0.5939 | Remote Similarity | NPD1731 | Clinical (unspecified phase) |
0.5931 | Remote Similarity | NPD578 | Discontinued |
0.5928 | Remote Similarity | NPD4495 | Phase 1 |
0.5921 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.5912 | Remote Similarity | NPD1063 | Phase 2 |
0.5909 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.5909 | Remote Similarity | NPD8838 | Approved |
0.5906 | Remote Similarity | NPD9084 | Phase 2 |
0.5886 | Remote Similarity | NPD3695 | Approved |
0.5886 | Remote Similarity | NPD3696 | Approved |
0.5867 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.5867 | Remote Similarity | NPD2902 | Phase 2 |
0.5848 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.5839 | Remote Similarity | NPD171 | Discontinued |
0.5839 | Remote Similarity | NPD1061 | Clinical (unspecified phase) |
0.5827 | Remote Similarity | NPD9415 | Clinical (unspecified phase) |
0.5827 | Remote Similarity | NPD9196 | Phase 2 |
0.5813 | Remote Similarity | NPD1451 | Approved |
0.5806 | Remote Similarity | NPD5340 | Clinical (unspecified phase) |
0.58 | Remote Similarity | NPD9544 | Approved |
0.58 | Remote Similarity | NPD78 | Approved |
0.5789 | Remote Similarity | NPD3130 | Discontinued |
0.5779 | Remote Similarity | NPD9650 | Phase 3 |
0.5776 | Remote Similarity | NPD5342 | Clinical (unspecified phase) |
0.5743 | Remote Similarity | NPD9290 | Approved |
0.5725 | Remote Similarity | NPD9197 | Discontinued |
0.5724 | Remote Similarity | NPD300 | Approved |
0.5724 | Remote Similarity | NPD757 | Phase 3 |
0.5704 | Remote Similarity | NPD613 | Phase 2 |
0.5696 | Remote Similarity | NPD9628 | Approved |
0.5696 | Remote Similarity | NPD9133 | Approved |
0.5687 | Remote Similarity | NPD875 | Clinical (unspecified phase) |
0.568 | Remote Similarity | NPD9429 | Discontinued |
0.5672 | Remote Similarity | NPD5080 | Phase 2 |
0.5649 | Remote Similarity | NPD9103 | Approved |
0.5649 | Remote Similarity | NPD9102 | Approved |
0.5632 | Remote Similarity | NPD691 | Discontinued |
0.5622 | Remote Similarity | NPD7486 | Phase 1 |
0.5622 | Remote Similarity | NPD5079 | Phase 2 |
0.5621 | Remote Similarity | NPD1085 | Approved |
0.5621 | Remote Similarity | NPD1775 | Approved |
0.562 | Remote Similarity | NPD223 | Clinical (unspecified phase) |
0.56 | Remote Similarity | NPD2221 | Clinical (unspecified phase) |
PubChem CID   | 187790 |
ChEMBL   | CHEMBL68908 |
ZINC   |
Molecular Weight:   | 267.10 |
ALogP:   | -1.9925 |
MLogP:   | 1.57 |
XLogP:   | -1.042 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 135.98 |
# H-Bond Aceptor:   | 9 |
# H-Bond Donor:   | 5 |
# Rings:   | 3 |
# Heavy Atoms:   | 19 |